Correlation Between Connect Biopharma and Catalent
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Catalent, you can compare the effects of market volatilities on Connect Biopharma and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Catalent.
Diversification Opportunities for Connect Biopharma and Catalent
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Connect and Catalent is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Catalent go up and down completely randomly.
Pair Corralation between Connect Biopharma and Catalent
If you would invest (100.00) in Catalent on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Catalent or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Connect Biopharma Holdings vs. Catalent
Performance |
Timeline |
Connect Biopharma |
Catalent |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Connect Biopharma and Catalent Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Connect Biopharma and Catalent
The main advantage of trading using opposite Connect Biopharma and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Catalent vs. IQVIA Holdings | Catalent vs. West Pharmaceutical Services | Catalent vs. Charles River Laboratories | Catalent vs. Bio Rad Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |